Search Results - roger+zou

4 Results Sort By:
Improving the sensitivity of CRISPR off-target detection through modulation of DNA repair
Value Proposition:·        Utilizes components of existing workflow to better detect off-target gene editing·        Capable for use in in vivo or in vitro settings·        Maximizes impact of CRISPR-Cas9 in therapeutic developmentTechnology Description·        Researchers at Johns Hopkins have developed a method to detect off-target editing with high...
Published: 10/4/2024   |   Inventor(s): Roger Zou, Yang Liu, Taekjip Ha, Oscar Reyes Gaido
Keywords(s):  
Category(s): Technology Classifications > Therapeutic Modalities > Cell Therapies, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
Nucleic Acid Detection Using a CRISPR Nuclease Actuator
Unmet Need / Invention Novelty: Nucleic acid-based diagnostics are useful for detection of infection, disease, and/or genetic variants. There is a need to develop improved detection methods with enhanced speed, specificity, sensitivity, at low cost that can be used for diagnostic applications.Technical Details: Researchers at Johns Hopkins have developed...
Published: 10/4/2024   |   Inventor(s): Taekjip Ha, Roger Zou
Keywords(s):  
Category(s): Clinical and Disease Specializations, Technology Classifications > Diagnostics
Very Fast and Efficient Light-inducible CRISPR/Cas9 System for Genome Editing
Unmet NeedSince CRISPR has been proposed as a genome editing tool in 2012, it has revolutionized the field and created excitement extending beyond the genome editing scientific community. Due to its simplicity and efficiency, CRISPR-Cas9 systems have already shown promise in multiple fields, e.g., medicine, agriculture and even biofuels (through CRISPR-edited...
Published: 10/4/2024   |   Inventor(s): Taekjip Ha, Yang Liu, Roger Zou, Bin Wu
Keywords(s): Discovery/Research Tools, Enzymes, Recombinant Proteins, Research Reagent
Category(s): Technology Classifications > Research Tools > Nucleic Acids
A CRISPR-Cas9 Platform with an Intrinsic Off-switch and Enhanced Specificity
Unmet NeedThe CRISPR/Cas9 system is a revolutionary genome editing tool that has opened up new opportunities in biological research and disease treatments. However, prolonged activity of Cas9 endonuclease inside the cell could undermine the efficacy of this system as it increases the risk of deleterious side-effects, such as off-target editing, genotoxicity,...
Published: 10/4/2024   |   Inventor(s): Taekjip Ha, Roger Zou, Yang Liu
Keywords(s): Discovery/Research Tools, Enzymes, Recombinant Proteins, Research Reagent
Category(s): Technology Classifications > Research Tools > Nucleic Acids
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum